D'Halluin Pierre-Nicolas, Delvaux Michel, Lapalus Marie-Georges, Sacher-Huvelin Sylvie, Ben Soussan Emmanuel, Heyries Laurent, Filoche Bernard, Saurin Jean-Christophe, Gay Gerard, Heresbach Denis
Gastrointest Endosc. 2005 Feb;61(2):243-9. doi: 10.1016/s0016-5107(04)02587-8.
The "Suspected Blood Indicator" (SBI), a feature included in the software for interpretation of capsule endoscopy (CE), is designed to facilitate detection of bleeding lesions in the small bowel. This study evaluated the sensitivity and the specificity of the SBI in patients who underwent CE for obscure GI bleeding (OGIB).
CE recordings from patients with OGIB recruited in 7 centers were read by experts blinded to the red SBI tags. They classified lesions of interest as bleeding or as having a potential for bleeding that was high (P2), low (P1), or absent (P0). The SBI tags then were marked by a another investigator. Concordance was acknowledged when frames selected by the expert reader, and those tagged by the SBI had the same time code.
A total of 156 recordings were evaluated. In 83, there was either no lesion (n = 71) or a P0 lesion (n = 12); these CE recordings were regarded as normal. Among the 73 abnormal recordings, 114 P2 and 92 P1 lesions were identified. A total of 154 red tags were analyzed. Sensitivity, specificity, and positive and negative predictive values of SBI were 37%, 59%, 50%, and 46%, respectively, for detection of the presence of a P2 or P1 lesion in front of a red tag.
SBI-based detection of intestinal lesions with the potential for bleeding is of limited clinical value in practice and does not reduce the time required for interpretation of CE.
“疑似出血指标”(SBI)是胶囊内镜(CE)解读软件中的一项功能,旨在便于检测小肠出血性病变。本研究评估了SBI在因不明原因胃肠道出血(OGIB)接受CE检查的患者中的敏感性和特异性。
来自7个中心的OGIB患者的CE记录由对红色SBI标签不知情的专家进行解读。他们将感兴趣的病变分类为出血性病变或具有高(P2)、低(P1)或无(P0)出血可能性的病变。然后由另一名研究人员标记SBI标签。当专家读者选择的帧与SBI标记的帧具有相同的时间代码时,则认为两者一致。
共评估了156份记录。其中83份记录中要么没有病变(n = 71),要么为P0病变(n = 12);这些CE记录被视为正常记录。在73份异常记录中,识别出114个P2病变和92个P1病变。共分析了154个红色标签。对于在红色标签前检测P2或P1病变的存在,SBI的敏感性、特异性、阳性预测值和阴性预测值分别为37%、59%、50%和46%。
基于SBI检测有出血可能性的肠道病变在实际临床中价值有限,且不能减少CE解读所需的时间。